{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:03:46Z","timestamp":1780401826175,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672264, 81871858"],"award-info":[{"award-number":["81672264, 81871858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10557-020-06980-4","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T08:03:17Z","timestamp":1589184197000},"page":"503-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and Safety of Inorganic Nitrate Versus Placebo Treatment in Heart Failure with Preserved Ejection Fraction"],"prefix":"10.1007","volume":"34","author":[{"given":"Yajun","family":"Gui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minzhi","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunyan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"issue":"8","key":"6980_CR1","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","volume":"50","author":"GC Fonarow","year":"2007","unstructured":"Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry. J Am Coll Cardiol. 2007;50(8):768\u201377.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"6980_CR2","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1093\/eurheartj\/ehr254","volume":"33","author":"Meta-analysis Global Group in Chronic Heart F","year":"2012","unstructured":"Meta-analysis Global Group in Chronic Heart F. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J. 2012;33(14):1750\u20137.","journal-title":"Eur Heart J"},{"issue":"10","key":"6980_CR3","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.jacc.2005.07.051","volume":"46","author":"M Guazzi","year":"2005","unstructured":"Guazzi M, Myers J, Arena R. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J Am Coll Cardiol. 2005;46(10):1883\u201390.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"6980_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jchf.2018.03.003","volume":"6","author":"YNV Reddy","year":"2018","unstructured":"Reddy YNV, Olson TP, Obokata M, Melenovsky V, Borlaug BA. Hemodynamic correlates and diagnostic role of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. JACC Heart Fail. 2018;6(8):665\u201375.","journal-title":"JACC Heart Fail"},{"issue":"31","key":"6980_CR5","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1093\/eurheartj\/ehy301","volume":"39","author":"CSP Lam","year":"2018","unstructured":"Lam CSP, Voors AA, de Boer RA, Solomon SD, van Veldhuisen DJ. Heart failure with preserved ejection fraction: from mechanisms to therapies. Eur Heart J. 2018;39(31):2780\u201392.","journal-title":"Eur Heart J"},{"issue":"1","key":"6980_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1253\/circj.CJ-13-1103","volume":"78","author":"BA Borlaug","year":"2014","unstructured":"Borlaug BA. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction. Circ J. 2014;78(1):20\u201332.","journal-title":"Circ J"},{"issue":"11","key":"6980_CR7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jacc.2010.03.077","volume":"56","author":"BA Borlaug","year":"2010","unstructured":"Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, et al. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2010;56(11):845\u201354.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"6980_CR8","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","volume":"114","author":"BA Borlaug","year":"2006","unstructured":"Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC, et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation. 2006;114(20):2138\u201347.","journal-title":"Circulation."},{"issue":"9","key":"6980_CR9","doi-asserted-by":"publisher","first-page":"H1364","DOI":"10.1152\/ajpheart.00004.2014","volume":"306","author":"DW Kitzman","year":"2014","unstructured":"Kitzman DW, Nicklas B, Kraus WE, Lyles MF, Eggebeen J, Morgan TM, et al. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2014;306(9):H1364\u201370.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"6980_CR10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.amjcard.2013.12.031","volume":"113","author":"MJ Haykowsky","year":"2014","unstructured":"Haykowsky MJ, Kouba EJ, Brubaker PH, Nicklas BJ, Eggebeen J, Kitzman DW. Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Cardiol. 2014;113(7):1211\u20136.","journal-title":"Am J Cardiol"},{"issue":"4","key":"6980_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"6980_CR12","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","volume":"373","author":"MM Redfield","year":"2015","unstructured":"Redfield MM, Anstrom KJ, Levine JA, Koepp GA, Borlaug BA, Chen HH, et al. Isosorbide Mononitrate in heart failure with preserved ejection fraction. N Engl J Med. 2015;373(24):2314\u201324.","journal-title":"N Engl J Med"},{"issue":"2","key":"6980_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrd2466","volume":"7","author":"JO Lundberg","year":"2008","unstructured":"Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008;7(2):156\u201367.","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"6980_CR14","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1002\/ejhf.966","volume":"19","author":"JN Patel","year":"2017","unstructured":"Patel JN, Shah SJ. Inorganic vs. organic nitrates for heart failure with preserved ejection fraction: it's not all in your head! Eur J Heart Fail. 2017;19(11):1516\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"6980_CR15","first-page":"428","volume":"4","author":"J Eggebeen","year":"2016","unstructured":"Eggebeen J, Kim-Shapiro DB, Haykowsky M, Morgan TM, Basu S, Brubaker P, et al. One week of daily dosing with beetroot juice improves submaximal endurance and blood pressure in older patients with heart failure and preserved ejection fraction. JACC: Heart Fail. 2016;4(6):428\u201337.","journal-title":"JACC: Heart Fail"},{"issue":"4","key":"6980_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1161\/CIRCULATIONAHA.114.012957","volume":"131","author":"P Zamani","year":"2015","unstructured":"Zamani P, Rawat D, Shiva-Kumar P, Geraci S, Bhuva R, Konda P, et al. Effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction. Circulation. 2015;131(4):371\u201380.","journal-title":"Circulation."},{"issue":"7","key":"6980_CR17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.116.309832","volume":"120","author":"P Zamani","year":"2017","unstructured":"Zamani P, Tan V, Soto-Calderon H, Beraun M, Brandimarto JA, Trieu L, et al. Pharmacokinetics and pharmacodynamics of inorganic nitrate in heart failure with preserved ejection fraction. Circ Res. 2017;120(7):1151\u201361.","journal-title":"Circ Res"},{"issue":"17","key":"6980_CR18","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1001\/jama.2018.14852","volume":"320","author":"BA Borlaug","year":"2018","unstructured":"Borlaug BA, Anstrom KJ, Lewis GD, Shah SJ, Levine JA, Koepp GA, et al. Effect of inorganic nitrite vs placebo on exercise capacity among patients with heart failure with preserved ejection fraction: the INDIE-HFpEF randomized clinical trial. Jama. 2018;320(17):1764\u201373.","journal-title":"Jama."},{"key":"6980_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.niox.2017.05.005","volume":"69","author":"HA Shaltout","year":"2017","unstructured":"Shaltout HA, Eggebeen J, Marsh AP, Brubaker PH, Laurienti PJ, Burdette JH, et al. Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and\/or heart failure with preserved ejection fraction. Nitric Oxide Biol Chem. 2017;69:78\u201390.","journal-title":"Nitric Oxide Biol Chem"},{"issue":"15","key":"6980_CR20","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.jacc.2015.07.067","volume":"66","author":"BA Borlaug","year":"2015","unstructured":"Borlaug BA, Koepp KE, Melenovsky V. Sodium nitrite improves exercise hemodynamics and ventricular performance in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2015;66(15):1672\u201382.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"6980_CR21","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1161\/CIRCRESAHA.116.309184","volume":"119","author":"BA Borlaug","year":"2016","unstructured":"Borlaug BA, Melenovsky V, Koepp KE. Inhaled sodium nitrite improves rest and exercise hemodynamics in heart failure with preserved ejection fraction. Circ Res. 2016;119(7):880\u20136.","journal-title":"Circ Res"},{"issue":"4","key":"6980_CR22","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6579\/aab2ef","volume":"39","author":"F Londono-Hoyos","year":"2018","unstructured":"Londono-Hoyos F, Zamani P, Beraun M, Vasim I, Segers P, Chirinos JA. Effect of organic and inorganic nitrates on cerebrovascular pulsatile power transmission in patients with heart failure and preserved ejection fraction. Physiol Meas. 2018;39(4):044001.","journal-title":"Physiol Meas"},{"issue":"18","key":"6980_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89620","volume":"1","author":"MA Simon","year":"2016","unstructured":"Simon MA, Vanderpool RR, Nouraie M, Bachman TN, White PM, Sugahara M, et al. Acute hemodynamic effects of inhaled sodium nitrite in pulmonary hypertension associated with heart failure with preserved ejection fraction. JCI Insight. 2016;1(18):e89620.","journal-title":"JCI Insight"},{"issue":"2","key":"6980_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jacc.2017.05.029","volume":"70","author":"YNV Reddy","year":"2017","unstructured":"Reddy YNV, Andersen MJ, Obokata M, Koepp KE, Kane GC, Melenovsky V, et al. Arterial stiffening with exercise in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol. 2017;70(2):136\u201348.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"6980_CR25","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/ejhf.885","volume":"19","author":"JA Chirinos","year":"2017","unstructured":"Chirinos JA, Londono-Hoyos F, Zamani P, Beraun M, Haines P, Vasim I, et al. Effects of organic and inorganic nitrate on aortic and carotid haemodynamics in heart failure with preserved ejection fraction. Eur J Heart Fail. 2017;19(11):1507\u201315.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"6980_CR26","doi-asserted-by":"publisher","first-page":"e003534","DOI":"10.1161\/CIRCHEARTFAILURE.116.003534","volume":"10","author":"SL Lim","year":"2017","unstructured":"Lim SL, Benson L, Dahlstrom U, Lam CSP, Lund LH. Association Between Use of Long-Acting Nitrates and Outcomes in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2017;10(4):e003534.","journal-title":"Circ Heart Fail"},{"issue":"7","key":"6980_CR27","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.mayocp.2018.11.032","volume":"94","author":"T Tsujimoto","year":"2019","unstructured":"Tsujimoto T, Kajio H. Use of nitrates and risk of cardiovascular events in patients with heart failure with preserved ejection fraction. Mayo Clin Proc. 2019;94(7):1210\u201320.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"6980_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.nutres.2012.02.002","volume":"32","author":"GD Miller","year":"2012","unstructured":"Miller GD, Marsh AP, Dove RW, Beavers D, Presley T, Helms C, et al. Plasma nitrate and nitrite are increased by a high-nitrate supplement but not by high-nitrate foods in older adults. Nutr Res. 2012;32(3):160\u20138.","journal-title":"Nutr Res"},{"issue":"2","key":"6980_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1161\/CIRCHEARTFAILURE.114.001551","volume":"8","author":"M Santos","year":"2015","unstructured":"Santos M, Opotowsky AR, Shah AM, Tracy J, Waxman AB, Systrom DM. Central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: implications for heart failure with preserved ejection fraction. Circ Heart Fail. 2015;8(2):278\u201385.","journal-title":"Circ Heart Fail"},{"issue":"6","key":"6980_CR30","doi-asserted-by":"crossref","first-page":"e001293","DOI":"10.1161\/JAHA.114.001293","volume":"3","author":"VP van Empel","year":"2014","unstructured":"van Empel VP, Mariani J, Borlaug BA, Kaye DM. Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction. J Am Heart Assoc. 2014;3(6):e001293.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"6980_CR31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1161\/CIRCULATIONAHA.114.014149","volume":"131","author":"R Vanderpool","year":"2015","unstructured":"Vanderpool R, Gladwin MT. Harnessing the nitrate-nitrite-nitric oxide pathway for therapy of heart failure with preserved ejection fraction. Circulation. 2015;131(4):334\u20136.","journal-title":"Circulation."},{"issue":"1","key":"6980_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/CIRCHEARTFAILURE.114.001731","volume":"8","author":"MJ Andersen","year":"2015","unstructured":"Andersen MJ, Olson TP, Melenovsky V, Kane GC, Borlaug BA. Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure. Circ Heart Fail. 2015;8(1):41\u20138.","journal-title":"Circ Heart Fail"},{"issue":"7","key":"6980_CR33","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/eurjhf\/hft026","volume":"15","author":"MM Abudiab","year":"2013","unstructured":"Abudiab MM, Redfield MM, Melenovsky V, Olson TP, Kass DA, Johnson BD, et al. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail. 2013;15(7):776\u201385.","journal-title":"Eur J Heart Fail"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-06980-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-020-06980-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-06980-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:06:14Z","timestamp":1620691574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-020-06980-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["6980"],"URL":"https:\/\/doi.org\/10.1007\/s10557-020-06980-4","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"11 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors<b>.<\/b>","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}]}}